Join us for the Spring Series
of the St Mary’s Infection & Immunity Seminars (hybrid)
(special lecture – Thurs 25th May)
Dr Michael Chan – University of Hong Kong
Biography:
Dr. Michael Chan ‘s main research interests are the virus-host interaction and pathogenesis of influenza virus and coronavirus (SARS-CoV-2, SARS-CoV and MERS-CoV) using ex vivo human respiratory explant cultures and in vitro well-differentiated human respiratory epithelial cells. Major focuses of his current work are: (1) Risk assessment of influenza virus and coronavirus using ex vivo explants and in vitro respiratory epithelial cells model. (2) Mechanism of lung injury upon severe influenza virus and coronavirus infection (3) Human nasal, nasopharyngeal, airway and distal lung organoids development and risk assessment for emerging infectious diseases (4) Role of human distal airway stem cells in respiratory epithelium regeneration upon influenza H5N1 virus, SARS-CoV-2, MERS-CoV and SARS-CoV infection. (5) Role of mesenchymal stromal cells and exosomes/microvesicles in reverse influenza H5N1 associated acute lung injury (6) Novel therapeutic options for severe human influenza virus and coronavirus infection, e.g. COVID-19.
Dr. Michael Chan received his PhD degree in Medical Science from the Chinese University of Hong Kong, followed by the post-doctoral training in influenza virus and infectious diseases with Prof. Malik Peiris at the University of Hong Kong since 2004.
Dr. Chan is ranked by Essential Science Indicator (ISI) as a “top 1% most-cited international scientist” in the world since 2009. He has published over 120 manuscripts; many of them are in high impact journals including Lancet Respiratory Medicine, Nature, Nature Medicine, Nature Microbiology, PNAS
join us in person:
Cockburn LT, QEQM building, St Mary’s Campus
and online via teams:
Click here to join the meeting
Meeting ID: 383 516 857 555
Passcode: GQhFPS
